$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Monounsaturated Fatty Acid Diets Improve Glycemic Tolerance through Increased Secretion of Glucagon-Like Peptide-1* 원문보기

Endocrinology, v.142 no.3, 2001년, pp.1148 - 1155  

Rocca, Antonio S. (Departments of Physiology (A.S.R., J.L.G., J.K., P.L.B.) University of Toronto, Toronto, Ontario, Canada) ,  LaGreca, Jonathon (Departments of Physiology (A.S.R., J.L.G., J.K., P.L.B.) University of Toronto, Toronto, Ontario, Canada) ,  Kalitsky, Juliana (Departments of Physiology (A.S.R., J.L.G., J.K., P.L.B.) University of Toronto, Toronto, Ontario, Canada) ,  Brubaker, Patricia L. (Departments of Physiology (A.S.R., J.L.G., J.K., P.L.B.) University of Toronto, Toronto, Ontario, Canada)

Abstract AI-Helper 아이콘AI-Helper

Diets enriched in monounsaturated fatty acids (MUFA)s have been shown to benefit glycemic control. Furthermore, MUFAs specifically stimulate secretion of the antidiabetic hormone, Glucagon-like peptide-1 (GLP-1) in vitro. To determine whether the MUFA-induced benefit in glycemic tolerance in vivo is...

참고문헌 (63)

  1. J Biol Chem Holst 269 18827 1994 10.1016/S0021-9258(17)32241-X Proglucagon processing in porcine and human pancreas. 

  2. Mol Endocrinol Dhanvantari 10 342 1996 Role of prohormone convertases in the tissue-specific processing of proglucagon. 

  3. J Endocrinol Elliott 138 159 1993 10.1677/joe.0.1380159 Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. 

  4. Digestion D’Alessio 54 377 1993 Response of tGLP-1 to nutrients in humans. 

  5. Proc Natl Acad Sci USA Drucker 84 3434 1987 10.1073/pnas.84.10.3434 Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. 

  6. J Clin Invest Mojsov 79 616 1987 10.1172/JCI112855 Insulinotropin: glucagon-like peptide I(7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. 

  7. FEBS Lett Holst 211 169 1987 10.1016/0014-5793(87)81430-8 Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. 

  8. Lancet Kreymann 2 1300 1987 10.1016/S0140-6736(87)91194-9 Glucagon-like peptide-1 7-36: a physiological incretin in man. 

  9. Diabetes Komatsu 38 902 1989 10.2337/diab.38.7.902 Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide. 

  10. J Clin Invest Nauck 91 301 1993 10.1172/JCI116186 Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. 

  11. Diabetes Care Creutzfeldt 19 580 1996 10.2337/diacare.19.6.580 Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. 

  12. Dig Dis Sci Schjoldager 34 703 1989 10.1007/BF01540341 GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans. 

  13. J Clin Invest Schirra 97 92 1996 10.1172/JCI118411 Gastric emptying and release of incretin hormones after glucose ingestion in humans. 

  14. J Clin Invest D’Alessio 93 2263 1994 10.1172/JCI117225 Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. 

  15. Diabetes D’Alessio 44 1433 1995 10.2337/diab.44.12.1433 Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes-a physiological role of glucagon-like peptide I. 

  16. Diabetes Sandhu 48 1045 1999 10.2337/diabetes.48.5.1045 Glucagon-like peptide-1 increases insulin sensitivity in depancreatized dogs. 

  17. Nature Turton 379 69 1996 10.1038/379069a0 A role for glucagon-like peptide-1 in the central regulation of feeding. 

  18. Endocrinology Brubaker 128 3175 1991 10.1210/endo-128-6-3175 Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. 

  19. Endocrinology Brubaker 139 4108 1998 10.1210/endo.139.10.6228 Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. 

  20. Endocrinology Damholt 139 2085 1998 10.1210/endo.139.4.5921 Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent insulinotropic peptide but unaffected by glucose. 

  21. Am J Physiol Fischer 273 E815 1997 Intestinal growth is associated with elevated levels of glucagon-like peptide-2 in diabetic rats 

  22. Endocrinology Dumoulin 136 5182 1995 10.1210/endo.136.11.7588257 Regulation of glucagon-like peptide-1-(7-36)amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum. 

  23. Endocrinology Rocca 140 1687 1999 10.1210/endo.140.4.6643 Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. 

  24. J Clin Endocrinol Metab Balks 82 786 1997 Rapid oscillations in plasma glucagon-like peptide-1 (GLP- 1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. 

  25. Endocrinology Roberge 137 2383 1996 10.1210/endo.137.6.8641190 Gastrin-releasing peptide is a novel mediator of proximal nutrient-induced proglucagon-derived peptide secretion from the distal gut. 

  26. Am J Physiol Ferraris 259 G822 1990 Luminal glucose concentrations in the gut under normal conditions 

  27. Endocrinology Rocca 136 5593 1995 10.1210/endo.136.12.7588313 Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures. 

  28. Diabetes Garg 41 1278 1992 10.2337/diab.41.10.1278 Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM. 

  29. Diabetes Care Garg 15 1572 1992 10.2337/diacare.15.11.1572 Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM. 

  30. Diabetes Care Garg 17 242 1994 10.2337/diacare.17.3.242 High-monounsaturated fat diet for diabetic patients. 

  31. Ann NY Acad Sci Riccardi 683 192 1993 10.1111/j.1749-6632.1993.tb35706.x Comparison of the metabolic effects of fat-modified vs low fat diets. 

  32. Diabetes Low 45 569 1996 10.2337/diab.45.5.569 Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. 

  33. Br J Nutr[ Suppl 1] Riccardi 83 S143 2000 Dietary treatment of the metabolic syndrome-the optimal diet 

  34. Clin Nutr [Suppl 2] Wright 17 35 1998 10.1016/S0261-5614(98)80016-2 Effect of high-carbohydrate versus high-monounsaturated fatty acid diet on metabolic control in diabetes and hyperglycemic patients. 

  35. Metabolism Parillo 41 1373 1992 10.1016/0026-0495(92)90111-M A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. 

  36. J Clin Invest Schirra 101 1421 1998 10.1172/JCI1349 Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. 

  37. Diabetes Kolligs 44 16 1995 10.2337/diab.44.1.16 Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. 

  38. Mol Endocrinol Drucker 8 1646 1994 Activation of proglucagon gene transcription by protein kinase A in a novel mouse enteroendocrine cell line. 

  39. Endocrinology Brubaker 123 220 1988 10.1210/endo-123-1-220 Control of glucagon-like immunoreactive peptide secretion from fetal rat intestinal cultures. 

  40. Regul Pept Tucker 62 29 1996 10.1016/0167-0115(95)00167-0 Proglucagon processing in islet and intestinal cell lines. 

  41. J Biol Chem Lowry 193 265 1951 10.1016/S0021-9258(19)52451-6 Protein measurement with the Folin phenol reagent. 

  42. Lipids Cunnane 30 781 1995 10.1007/BF02537807 Synthesis of linoleate and alpha-linolenate by chain elongation in the rat. 

  43. J Nutr Biochem Opara 4 498 1993 10.1016/0955-2863(93)90085-B Essential fatty acids (EFA): role in pancreatic hormone release and concomitant metabolic effect. 

  44. J Nutr Dyer 121 1548 1991 10.1093/jn/121.10.1548 Dietary essential fatty acids change the fatty acid profile of rat neural mitochondria over time. 

  45. Am J Clin Nutr Innis 71 238 2000 10.1093/ajcn/71.1.238S Essential fatty acids in infant nutrition: lessons and limitations from animal studies in relation to studies on infant fatty acid requirements. 

  46. Diabetes Care Campbell 17 177 1994 10.2337/diacare.17.3.177 The high-monounsaturated fat diet as a practical alternative for NIDDM. 

  47. Am J Clin Nutr Thomsen 69 1135 1999 10.1093/ajcn/69.6.1135 Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. 

  48. Diabetes Gremlich 44 1202 1995 10.2337/diab.44.10.1202 Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. 

  49. Diabetes Hunnicutt 43 540 1994 10.2337/diab.43.4.540 Saturated fatty acid-induced insulin resistance in rat adipocytes. 

  50. Metabolism Manco 49 220 2000 10.1016/S0026-0495(00)91377-5 Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. 

  51. Metabolism Hendrick 42 1 1993 10.1016/0026-0495(93)90163-I Glucagon-like peptide-1-(7-37) suppresses hyperglycemia in rats. 

  52. FEBS Lett Valverde 349 313 1994 10.1016/0014-5793(94)00699-7 Glucagon-like peptide 1: a potent glycogenic hormone. 

  53. Digestion Wheeler 54 348 1993 The rat glucagon-like peptide 1 receptor can couple to adenylyl cyclase, phospholipase C and the free cytosolic calcium level. 

  54. Endocrinology Valverde 132 75 1993 10.1210/endo.132.1.8380388 Presence and characterization of glucagon-like peptide-1(7-36)amide receptors in solubilized membranes of rat adipose tissue. 

  55. Diabetologia Orskov 39 1227 1996 10.1007/BF02658511 GLP-1 does not acutely affect insulin sensitivity in healthy man. 

  56. JAMA Garg 271 1421 1994 10.1001/jama.1994.03510420053034 Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus [see comments]. 

  57. Endocrinology Roberge 128 3169 1991 10.1210/endo-128-6-3169 Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients. 

  58. Endocrinology Roberge 133 233 1993 10.1210/endo.133.1.8319572 Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. 

  59. J Biol Chem Nakanishi 267 16347 1992 10.1016/S0021-9258(18)42008-X Purification and characterization of the zeta isoform of protein kinase C from bovine kidney. 

  60. Trends Pharmacol Sci Wilkinson 15 53 1994 10.1016/0165-6147(94)90110-4 Protein kinase C: is its pivotal role in cellular activation over-stated. 

  61. Biochemistry Goldberg 37 5623 1998 10.1021/bi9719354 Synergistic effects of diacylglycerols and fatty acids on membrane structure and protein kinase C activity. 

  62. Mol Cell Biochem Catala 137 135 1994 10.1007/BF00944075 Interaction of rat liver microsomes containing saturated or unsaturated fatty acids with fatty acid binding protein: peroxidation effect. 

  63. Biochim Biophys Acta Woodford 1145 257 1993 10.1016/0005-2736(93)90297-D Expression of liver fatty acid binding protein alters plasma membrane lipid composition and structure in transfected L-cell fibroblasts. 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로